Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...

Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference Loughborough, England, March 10, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...

Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...

Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...

Zelegent, Inc. Elevoplasty™ Procedure Receives U.S. Patent First issued patent of a portfolio of applications covering the new minimally-invasive procedure to treat snoring  IRVINE, CA, June 21, 2018 (GLOBE NEWSWIRE) -- Zelegent, Inc., a medical...